Non-Billable / Non-Specific Code
ICD-10-CM C53 is the diagnosis code for Malignant neoplasm of cervix uteri. This code falls under the section "Malignant neoplasms of female genital organs" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions should never be coded at the same time as C53. They are mutually exclusive:
Understanding where C53 sits in the ICD-10-CM classification helps ensure proper coding:
No, C53 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
C53 is the ICD-10-CM diagnosis code for "Malignant neoplasm of cervix uteri". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
C53 is located in Section C51-C58 — "Malignant neoplasms of female genital organs" within Chapter 2 of the ICD-10-CM Tabular List.
C53 has 4 sub-code(s) that provide more specific detail: C53.0, C53.1, C53.8, C53.9.
Use C53 when the patients documented diagnosis matches "Malignant neoplasm of cervix uteri" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant neoplasm of cervix uteri is C53.
No, C53 is non-billable. Use a more specific sub-code for primary diagnosis billing.
C53 is in Chapter 2 of the ICD-10-CM Tabular List.
Type 1 Excludes for C53 include: carcinoma in situ of cervix uteri (D06.-).
Yes, C53 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.